Lyell Immunopharma Inc. (LYEL)
NASDAQ: LYEL
· Real-Time Price · USD
10.62
-0.14 (-1.30%)
At close: Aug 15, 2025, 3:59 PM
10.58
-0.38%
After-hours: Aug 15, 2025, 04:10 PM EDT
Lyell Immunopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 60K | 65K | 61K | 63K | 54K | 68K | 130K | 165.39K | 143.39K | 35.86M | 36.35M | 39.12M | 41.87M | 8.76M | 10.65M | 10.14M | 8.46M | 8.95M |
Cost of Revenue | n/a | n/a | n/a | 5.06M | 10.16M | 14.7M | 19.73M | 19.26M | 18.33M | 17.52M | 16.47M | 15.87M | 11.69M | 7.96M | 6.99M | 3M | 3M | 3M |
Gross Profit | 52K | 65K | 61K | -4.99M | -10.11M | -14.63M | -19.6M | -19.1M | -18.19M | 18.34M | 19.88M | 23.25M | 30.18M | 795K | 3.66M | 7.14M | 5.46M | 5.95M |
Operating Income | -307.96M | -360.55M | -358.75M | -217.12M | -225.65M | -240.03M | -247.01M | -187.51M | -194.91M | -166.26M | -172.28M | -219.81M | -202.54M | -227.98M | -214.78M | -206.76M | -194.44M | -234.3M |
Interest Income | 14.75M | 21.11M | 24.07M | 26.23M | 26.88M | 25.77M | 23.45M | 19.82M | 15.46M | 11.15M | 7.05M | 3.92M | 1.94M | 1.21M | 1.17M | 1.46M | 2.29M | 3.95M |
Pretax Income | -331.4M | -334.52M | -342.99M | -203.99M | -210.26M | -228.34M | -234.63M | -181.71M | -201.11M | -173.54M | -174.73M | -258.43M | -237.05M | -263.32M | -250.22M | -205.37M | -192.21M | -230.28M |
Net Income | -331.4M | -334.52M | -342.99M | -203.99M | -210.26M | -228.34M | -300.3M | -244.93M | -268.15M | -240.59M | -175.67M | -261.81M | -236.62M | -262.89M | -250.22M | -205.37M | -192.21M | -230.28M |
Selling & General & Admin | 50.12M | 52.59M | 52.04M | 50.69M | 54.42M | 61.2M | 66.98M | 53.84M | 64.42M | 75.84M | 90.99M | 122.83M | 117.99M | 106.65M | 89.06M | 72.05M | 64.38M | 54.83M |
Research & Development | 166.47M | 171.88M | 171.6M | 164.55M | 168.9M | 176.11M | 177.57M | 135.99M | 133.75M | 129.99M | 121.19M | 140.44M | 130.27M | 132.99M | 138.69M | 154.5M | 147.57M | 198.27M |
Other Expenses | 139.62M | 136.14M | 135.17M | -3.3M | -994K | -344K | -542K | -32.46K | -2.86M | -2.55M | -2.38M | -2.43M | -1.16M | -1.26M | -161K | -71K | -59K | 76K |
Operating Expenses | 356.22M | 360.61M | 358.82M | 212.44M | 220.97M | 235.36M | 242.4M | 187.68M | 195.06M | 202.13M | 208.64M | 258.93M | 244.41M | 236.74M | 225.43M | 216.9M | 202.9M | 243.25M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 621K | 621K | 621K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 309.07M | 360.61M | 358.82M | 217.5M | 226.03M | 240.42M | 247.46M | 187.68M | 195.06M | 202.13M | 208.64M | 258.93M | 244.41M | 236.74M | 225.43M | 216.9M | 202.9M | 243.25M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 65.67M | 63.22M | 67.04M | 67.04M | 938K | 3.06M | -1.02M | -1.24M | -1.17M | -842K | -572K | -354K |
Shares Outstanding (Basic) | 14.79M | 295.1M | 266.54M | 256.31M | 255.4M | 254.25M | 253.09M | 251.32M | 250.2M | 249.59M | 249.57M | 248.32M | 246.31M | 244.18M | 242.74M | 239.79M | 238.55M | 246.58M |
Shares Outstanding (Diluted) | 14.79M | 295.1M | 266.54M | 256.31M | 255.4M | 254.25M | 253.09M | 251.32M | 250.2M | 249.59M | 249.57M | 248.32M | 246.31M | 244.18M | 242.74M | 239.79M | 238.55M | 246.58M |
EPS (Basic) | -3.96 | -1.25 | -1.31 | -0.8 | -0.83 | -0.91 | -0.94 | -0.76 | -0.84 | -0.73 | -0.74 | -1.05 | -0.98 | -1.09 | -1.03 | -0.85 | -0.79 | -0.95 |
EPS (Diluted) | -3.96 | -1.25 | -1.31 | -0.8 | -0.83 | -0.91 | -0.94 | -0.76 | -0.84 | -0.73 | -0.74 | -1.05 | -0.98 | -1.09 | -1.03 | -0.85 | -0.79 | -0.95 |
EBITDA | -156.33M | -204.02M | -200.64M | -197.45M | -205.56M | -219.78M | -226.76M | -182.05M | -189.93M | -162.18M | -168.82M | -201.08M | -184.33M | -210.94M | -200.18M | -196.25M | -186.92M | -228.83M |
EBIT | -170.54M | -222.07M | -220.27M | -217.12M | -225.65M | -240.03M | -247.01M | -195.9M | -203.29M | -174.65M | -180.67M | -219.81M | -202.54M | -227.98M | -214.78M | -206.76M | -194.44M | -234.3M |
Depreciation & Amortization | 13.15M | 18.05M | 19.63M | 19.66M | 20.09M | 20.25M | 20.25M | 19.79M | 18.85M | 17.52M | 16.47M | 15.87M | 15.78M | 15.91M | 14.94M | 12.4M | 9.41M | 6.52M |